Whole genome doubling (WGD) occurs early in tumorigenesis and generates geneticallyunstable tetraploid cells that fuel tumor development. Cells that undergo WGD (WGD + ) must adapt to accommodate their abnormal tetraploid state; however, the nature of these adaptations, and whether they confer vulnerabilities that can subsequently be exploited therapeutically, is unclear. Using sequencing data from ~10,000 primary human cancer samples and essentiality data from ~600 cancer cell lines, we show that WGD gives rise to common genetic traits that are accompanied by unique vulnerabilities. We reveal that WGD + cells are more dependent on spindle assembly checkpoint signaling, DNA replication factors, and proteasome function than WGDcells. We also identify KIF18A, which encodes for a mitotic kinesin, as being specifically required for the viability of WGD + cells. While loss of KIF18A is largely dispensable for accurate chromosome segregation during mitosis in WGDcells, its loss induces dramatic mitotic errors in WGD + cells, ultimately impairing cell viability. Collectively, our results reveal new strategies to specifically target WGD + cancer cells while sparing the normal, nontransformed WGDcells that comprise human tissue..
47Whole genome doubling (WGD) occurs early in tumorigenesis and generates genetically 48 unstable tetraploid cells that fuel tumor development. Cells that undergo WGD (WGD + ) 49 must adapt to accommodate their abnormal tetraploid state; however, the nature of these 50 adaptations, and whether they confer vulnerabilities that can subsequently be exploited 51 therapeutically, is unclear. Using sequencing data from ~10,000 primary human cancer 52 samples and essentiality data from ~600 cancer cell lines, we show that WGD gives rise to 53 common genetic traits that are accompanied by unique vulnerabilities. We reveal that 54 WGD + cells are more dependent on spindle assembly checkpoint signaling, DNA 55 replication factors, and proteasome function than WGDcells. We also identify KIF18A, 56 which encodes for a mitotic kinesin, as being specifically required for the viability of 57 WGD + cells. While loss of KIF18A is largely dispensable for accurate chromosome 58 segregation during mitosis in WGDcells, its loss induces dramatic mitotic errors in 59 WGD + cells, ultimately impairing cell viability. Collectively, our results reveal new 60 strategies to specifically target WGD + cancer cells while sparing the normal, non-61 transformed WGDcells that comprise human tissue. 62The vast majority of human cells are diploid and numerous cell cycle controls exist to help 63 ensure that this state is maintained across successive cell divisions 1 . Despite these controls, 64 errors can occur that result in a whole genome doubling (WGD), in which a natively diploid cell 65 transitions to a tetraploid state 1-3 . It has been demonstrated that cells that have experienced a 66 WGD event (hereafter WGD + ) are oncogenic and can facilitate tumorigenesis 4,5 . WGD promotes 67 tumorigenesis in at least two ways: first, proliferating WGD + cells are genomically unstable and 68 rapidly accumulate both numerical and structural chromosomal abnormalities 5 , and second, 69 WGD + cells are better able to buffer against the negative effects of deleterious mutations and 70 ongoing chromosome instability 6-10 . Such traits enable nascent WGD + tumor cells to proliferate 71 in the presence of otherwise lethal genomic alterations while simultaneously sampling increased 72 genetic permutations, ultimately enabling phenotypic leaps that give rise to tumors 8,11 . WGD also 73 carries important clinical implications, with recent reports showing its correlation with advanced 74 metastatic disease and a worse overall prognosis 12,13 . 75 76 Given the oncogenic potential associated with WGD, tumor suppression mechanisms exist to limit 77 the proliferation of these unstable cells. WGD + cells activate both the p53 and Hippo tumor 78 suppressor pathways and are prone to apoptosis, senescence, and immune clearance [14][15][16] . WGD also 79gives rise to numerous abnormalities in cellular physiology that impair fitness 6,14,17 . Therefore, in 80 order to promote tumorigenesis, WGD + cells must adapt to overcome these barriers 5,14,18,19 . Thus, 81 while ...
Coronary vasospasm is a well-known entity causing acute chest syndrome and can lead to myocardial infarction, ventricular arrhythmias, and even sudden cardiac death. While there are extensive case series showing the association of coronary vasospasm with cocaine, studies reporting marijuana-induced coronary vasospasm are limited in number. We herein present a case of coronary vasospasm in a middle-aged African-American male who presented to the emergency department after an episode of syncope. His urine drug screen was positive only for marijuana. He had a transient elevation of ST segments on his EKG with concomitant wall motion abnormalities on echocardiogram and was later found to have vasospasm of coronary arteries on coronary angiogram without any evidence of focal atherosclerotic disease. Another interesting finding was the persistent inter-coronary communication or coronary arcade connecting the left circumflex artery to the right coronary artery. There was bi-directional flow through the inter-coronary communication and hence, we believe this communication prevented our patient from experiencing acute chest symptoms or myocardial infarction. It is important for the clinicians to recognize the association of marijuana with coronary vasospasm. At the same time, these patients should be treated as acute coronary syndromes until proven otherwise by ischemia evaluation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with đź’™ for researchers
Part of the Research Solutions Family.